ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,197Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1499

$1.47M Total Retail Price of All Prescriptions

Rank: 23 out of 1499

628 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 628 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 628 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,731 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,140 488 S3 1 4
LISINOPRIL 642 375 2 1
OMEPRAZOLE 600 279 3 5
FUROSEMIDE 589 384 4 7
RANITIDINE HCL 579 293 5 15
LEVOTHYROXINE SODIUM 546 402 6 2
PRAVASTATIN SODIUM 420 320 7 18
CARVEDILOL 401 290 8 22
METFORMIN HCL 397 155 9 8
POTASSIUM CHLORIDE 381 263 10 11
METOPROLOL SUCCINATE 368 239 11 20
AMLODIPINE BESYLATE 367 249 12 6
GABAPENTIN 310 133 13 13
TRAMADOL HCL 307 124 14 16
ATORVASTATIN CALCIUM 300 153 15 17
CRESTOR 270 153 16 34
WARFARIN SODIUM 265 190 17 12
CYMBALTA 263 96 18 40
SIMVASTATIN 262 161 19 3
CLOPIDOGREL 258 189 20 39
ZOLPIDEM TARTRATE 254 143 21 23
METOPROLOL TARTRATE 246 156 22 10
MELOXICAM 239 85 23 27
ROPINIROLE HCL 237 112 24 55
NEXIUM 236 95 25 28
TAMSULOSIN HCL 235 117 26 29
CELEBREX 210 111 27 77
HYDROCHLOROTHIAZIDE 206 104 28 9
TRICOR 191 101 29 103
CITALOPRAM HBR 188 131 30 14
TORSEMIDE 178 147 31 149
RAMIPRIL 177 122 32 127
DIOVAN 176 142 33 58
SPIRIVA 173 100 34 44
PROAIR HFA 171 48 35 30
SINGULAIR 167 54 36 67
GLIMEPIRIDE 166 129 37 38
PLAVIX 165 121 38 54
SERTRALINE HCL 164 117 39 24
ISOSORBIDE MONONITRATE ER 149 112 40 51
ADVAIR DISKUS 143 68 41 37
LIPITOR 132 65 42 107
ALLOPURINOL 132 86 42 36
CLONIDINE HCL 128 48 44 57
DONEPEZIL HCL 124 104 45 35
TRAZODONE HCL 122 34 46 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 75 46 25
ZETIA 117 100 48 91
FLUTICASONE PROPIONATE 115 44 49 31
ATENOLOL 114 58 50 21
LOVASTATIN 113 61 51 19
PANTOPRAZOLE SODIUM 112 57 52 48
TIZANIDINE HCL 110 17 53 105
ACTOS 110 84 53 145
NAPROXEN 110 60 53 63
POLYETHYLENE GLYCOL 3350 108 66 56 52
BUSPIRONE HCL 107 40 57 94
CIPROFLOXACIN HCL 106 71 58 65
TOPIRAMATE 106 32 58 128
LIDODERM 101 43 60 123
AMITRIPTYLINE HCL 97 49 R 61 49
MONTELUKAST SODIUM 95 28 62 133
SPIRONOLACTONE 94 57 63 61
DIOVAN HCT 94 70 63 122
JANUVIA 91 61 65 84
LEVOFLOXACIN 90 52 66 101
DILTIAZEM ER 90 68 66 124
PREDNISONE 90 49 66 42
FLUOXETINE HCL 89 34 69 43
PROMETHAZINE HCL 88 32 R 70 138
CYCLOBENZAPRINE HCL 88 21 R 70 41
NASONEX 85 34 72 198
PEN NEEDLE 85 34 72 120
LANTUS 84 50 74 46
DIGOXIN 83 70 75 56
VYTORIN 83 70 75 154
EVISTA 82 41 77 132
AMLODIPINE BESYLATE-BENAZEPRIL 79 43 78 109
VENLAFAXINE HCL ER 78 70 79 96
ALENDRONATE SODIUM 78 61 79 33
DETROL LA 78 54 79 155
HYDROXYZINE PAMOATE 76 34 R 82 194
GLIPIZIDE 76 50 82 64
BUPROPION HCL SR 76 12 82 151
SYNTHROID 74 38 85 68
NOVOLIN 70-30 73 61 86 204
LOVAZA 73 37 86 136
METHYLPREDNISOLONE 71 29 88 135
LOSARTAN POTASSIUM 71 61 88 26
QUETIAPINE FUMARATE 71 43 88 72
THEOPHYLLINE ANHYDROUS 68 29 91 238
ESCITALOPRAM OXALATE 68 27 91 76
BUPROPION XL 65 21 93 222
TRIAMCINOLONE ACETONIDE 65 33 93 126
LANTUS SOLOSTAR 65 19 93 89
IBUPROFEN 65 22 93 70
INSULIN SYRINGE 65 29 93 102
LEVETIRACETAM 64 19 98 142
COMBIVENT 64 28 98 78
PRADAXA 64 57 98 253
HYDRALAZINE HCL 63 44 101 118
AZITHROMYCIN 63 21 101 45
PROPRANOLOL HCL 62 30 103 115
PIOGLITAZONE HCL 62 46 R 103 290
ABILIFY 61 14 105 143
LYRICA 59 26 106 90
AMOX TR-POTASSIUM CLAVULANATE 58 24 107 160
MIRTAZAPINE 58 26 107 50
DOXEPIN HCL 57 22 109 244
AMOXICILLIN 56 36 110 113
THEO-24 55 36 111 454
SYMBICORT 55 13 111 121
ENDOCET 54 42 S2 113 111
PAROXETINE HCL 54 12 113 59
MECLIZINE HCL 53 21 115 186
HYDROXYZINE HCL 53 14 R 115 173
DOXYCYCLINE HYCLATE 53 27 115 106
NITROFURANTOIN MONO-MACRO 52 45 118 188
BACLOFEN 52 0 118 119
RISPERIDONE 51 35 120 74
METHOCARBAMOL 50 16 R 121 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.